TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 216 filers reported holding TG THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,549,684 | +177.1% | 215,527 | +38.8% | 0.01% | +180.0% |
| Q3 2022 | $920,000 | -3.0% | 155,321 | -30.4% | 0.01% | -28.6% |
| Q2 2022 | $948,000 | +4.3% | 223,088 | +851.8% | 0.01% | -30.0% |
| Q2 2021 | $909,000 | +168.1% | 23,438 | +34.6% | 0.01% | +100.0% |
| Q2 2020 | $339,000 | +32.4% | 17,413 | -24.6% | 0.01% | -37.5% |
| Q4 2019 | $256,000 | – | 23,095 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,813,779 | $33,568,000 | 3.32% |
| Opaleye Management Inc. | 300,000 | $3,579,000 | 1.50% |
| BRIDGER MANAGEMENT, LLC | 3,068,315 | $36,605,000 | 1.21% |
| SECTORAL ASSET MANAGEMENT INC | 1,521,667 | $18,153,000 | 0.77% |
| STONERIDGE INVESTMENT PARTNERS LLC | 332,576 | $3,968,000 | 0.53% |
| Eventide Asset Management | 537,600 | $6,414,000 | 0.32% |
| Baker Brothers Advisors | 2,003,991 | $23,908,000 | 0.20% |
| Quantitative Systematic Strategies LLC | 25,270 | $302,000 | 0.08% |
| Candriam S.C.A. | 236,200 | $2,818,000 | 0.08% |
| COLUMBUS CIRCLE INVESTORS | 705,389 | $8,415,000 | 0.07% |